Innate and adaptive immune responses in contact dermatitis: Analogy with infections

Giornale Italiano di Dermatologia e Venereologia

Volumn 144, Issue 2, 2009, Pages 173-185

  Freudenberg, M A ^a   Esser, P R ^b   Jakob, T ^b   Galanos, C ^a   Martin, S F ^b  

^a MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Dendritic cells; Dermatitis, allergic contact; Haptens; Immunity, innate; Infection; NOD like receptors; T lymphocytes; Toll like receptors

Indexed keywords

CONTACT ALLERGEN; CRYOPYRIN; HYALURONIC ACID; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; CELL MIGRATION; CELLULAR STRESS RESPONSE; CONTACT ALLERGY; DENDRITIC CELL; EFFECTOR CELL; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; KERATINOCYTE; MAST CELL; NATURAL KILLER CELL; RECEPTOR UPREGULATION; REGULATORY T LYMPHOCYTE; REVIEW; SKIN ALLERGY;

EID: 67649460877     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (122)

1. Martin SF. Chemical-induced contact hypersensitivity in the mouse model. In: Pichler WJ, editor. Drug hypersensitivity. Basel: Karger; 2007. p. 34-46.
2. Karlberg AT, Bergstrom MA, AT, Borje A, Luthman K, Nilsson JL. Allergic contact dermatitis - formation, structural requirements, and reactivity of skin sensitizers. Chem Res Toxicol 2008;21:53-69. (Pubitemid 351219708)
3. Bergstrom MA, Ott H, Carlsson A, Neis M, Zwadlo-Klarwasser G, Jonsson CA et al. A skin-like cytochrome P450 cocktail activates prohaptens to contact allergenic metabolites. J Invest Dermatol 2007;127:1145-1153 (Pubitemid 46625132)
4. Edele F, Esser PR, Lass C, Laszczyk MN, Oswald E, Strüh CM, Rensing-Ehl A et al. Innate and adaptive immune responses in allergic contact dermatitis and autoimmune skin diseases. Inflamm Allergy Drug Targets 2007;6:236-244
5. Grabbe S, Steinert M, Mahnke K, Schwarz A, Luger TA, Schwarz T. Dissection of antigenic and irritative effects of epicutaneously applied haptens in mice. Evidence that not the antigenic component but non-specific proinflammatory effects of haptens determine the concentration-dependent elicitation of allergic contact dermatitis. J Clin Invest 1996;98:1158-1164 (Pubitemid 26299929)
6. Bonneville M, Chavagnac C, Vocanson M, Rozieres A, Benetiere J, Pernet I et al. Skin contact irritation conditions the development and severity of allergic contact dermatitis. J Invest Dermatol 2007;127:1430-1435 (Pubitemid 46762985)
7. Mizuashi M, Ohtani T, Nakagawa S, Aiba S. Redox imbalance induced by contact sensitizers triggers the maturation of dendritic cells. J Invest Dermatol 2005;124:579-586 (Pubitemid 40381581)
8. Matsue H, Edelbaum D, Shalhevet D, Mizumoto N, Yang C, Mummert ME et al. Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J Immunol 2003;171:3010-3018 (Pubitemid 37093524)
9. Bruchhausen S, Zahn S, Valk E, Knop J, Becker D. Thiol antioxidants block the activation of antigen-presenting cells by contact sensitizers. J Invest Dermatol 2003;121:1039-1044 (Pubitemid 37430971)
10. Kim HJ, Barajas B, Wang M, Nel AE. Nrf2 activation by sulforaphane restores the age-related decrease of T(H)1 immunity: role of dendritic cells. J Allergy Clin Immunol 2008;121:1255-1261
11. Natsch A, Emter R. Skin sensitizers induce antioxidant response element dependent genes: application to the in vitro testing of the sensitization potential of chemicals. Toxicol Sci 2008;102:110-119
12. Ade N, Leon F, Pallardy M, Peiffer JL, Kerdine-Romer S, Tissier MH et al. HMOX1 and NQO1 genes are up-regulated in response to contact sensitizers in dendritic cells and THP-1 cell line: role of the Keap1/Nrf2 pathway. Toxicol Sci 2008;107:451-460
13. Martin SF, Jakob T. From innate to adaptive immune responses in contact hypersensitivity. Curr Opin Allergy Clin Immunol 2008;8:289-93.
14. Martin SF, Dudda JC, Bachtanian E, Lembo A, Liller S, Dürr C, Heimesaat MM et al. Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity. J Exp Med 2008;205:2151-62.
15. Watanabe H, Gaide O, Petrilli V, Martinon F, Contassot E, Roques S et al. Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol 2007;127:1956-1963 (Pubitemid 47075373)
16. Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS, Grant EP et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 2006;24:317-327
17. Kawai T, Akira S. Toll-like receptor and RIG-I-like receptor signaling. Ann N.Y. Acad Sci 2008;1143:1-20.
18. Palm NW, Medzhitov R. Pattern recognition receptors and control of adaptive immunity. Immunol Rev 2009;227:221-233
19. Beutler B. Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases. Immunol Rev 2009;227:248-263
20. Creagh EM, O'Neill LA. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 2006;27:352-357 (Pubitemid 44038661)
21. Martinon F. Detection of immune danger signals by NALP3. J Leukoc Biol 2008;83:507-511 (Pubitemid 351966858)
22. Mariathasan S, Monack DM. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 2007;7:31-40. (Pubitemid 46020825)
23. Sutterwala FS, Ogura Y, Flavell RA. The inflammasome in pathogen recognition and inflammation. J Leukoc Biol 2007;82:259-264 (Pubitemid 47230635)
24. Martin SF, Merfort I, Thierse HJ. Interactions of chemicals and metal ions with proteins and role for immune responses. Mini Rev Med Chem 2006;6:247-255
25. Meller S, Lauerma AI, Kopp FM, Winterberg F, Anthoni M, Muller A et al. Chemokine responses distinguish chemical-induced allergic from irritant skin inflammation: memory T cells make the difference. J Allergy Clin Immunol 2007;119:1470-1480 (Pubitemid 46855833)
26. Basketter DA. Skin sensitization: strategies for the assessment and management of risk. Br J Dermatol 2008;159:267-273 (Pubitemid 352009829)
27. Walsh G, Jefferis R. Post-translational modifications in the context of therapeutic proteins. Nat Biotechnol 2006;24:1241-1252 (Pubitemid 44564769)
28. Reinders J, Sickmann A. Modificomics: posttranslational modifications beyond protein phosphorylation and glycosylation. Biomol Eng 2007;24:169-177 (Pubitemid 46755013)
29. Sasaki Y, Aiba S. Dendritic cells and contact dermatitis. Clin Rev Allergy Immunol 2007;33:27-34.
30. Matsuzawa A, Saegusa K, Noguchi T, Sadamitsu C, Nishitoh H, Nagai S et al. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol 2005;6:587-592 (Pubitemid 41710729)
31. Lee, IT, Wang SW, Lee CW, Chang CC, Lin CC, Luo SF et al. Lipoteichoic acid induces HO-1 expression via the TLR2/MyD88/c-Src/NADPH oxidase pathway and Nrf2 in human tracheal smooth muscle cells. J Immunol 2008;181:5098-5110
32. Rushworth SA, MacEwan DJ, O'Connell MA. Lipopolysaccharide-induced expression of NAD(P)H:quinone oxidoreductase 1 and heme oxygenase-1 protects against excessive inflammatory responses in human monocytes. J Immunol 2008;181:6730-6737
33. Ogier-Denis E, Mkaddem SB, Vandewalle A. NOX enzymes and Toll-like receptor signaling. Semin Immunopathol 2008;30:291-300.
34. Tse HM, Milton MJ, Schreiner S, Profozich JL, Trucco M, Piganelli JD. Disruption of innate-mediated proinflammatory cytokine and reactive oxygen species third signal leads to antigen-specific hyporesponsiveness. J Immunol 2007;178:908-917 (Pubitemid 46095163)
35. Dinkova-Kostova AT, Holtzclaw WD, Kensler TW. The role of Keap1 in cellular protective responses. Chem Res Toxicol 2005;18:1779-91. (Pubitemid 43023036)
36. Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA 2002;99:11908-11913 (Pubitemid 34994497)
37. Furukawa M, Xing Y. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol Cell Biol 2005;25:162-171 (Pubitemid 40039808)
38. Chatila TA, Li N, Garcia-Lloret M, Kim HJ, Nel AE. T-cell effector pathways in allergic diseases: transcriptional mechanisms and therapeutic targets. J Allergy Clin Immunol 2008;121:812-823
39. Kim HJ, Barajas B, Chan RC, Nel AE. Glutathione depletion inhibits dendritic cell maturation and delayed-type hypersensitivity: implications for systemic disease and immunosenescence. J Allergy Clin Immunol 2007;119:1225-1233 (Pubitemid 46654168)
40. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004;4:181-189 (Pubitemid 38339084)
41. Laroux FS, Romero X, Wetzler L, Engel P, Terhorst C. Cutting edge: MyD88 controls phagocyte NADPH oxidase function and killing of gram-negative bacteria. J Immunol 2005;175:5596-5600 (Pubitemid 41508037)
42. Bae YS, Lee JH, Choi SH, Kim S, Almazan F, Witztum JL et al. Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ Res 2009;104:210-218
43. D'Autreaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007;8:813-824 (Pubitemid 47462134)
44. Gloire G, Legrand-Poels S, Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 2006;72:1493-1505 (Pubitemid 44666727)
45. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008;320:674-677 (Pubitemid 351928351)
46. O'Neill LA. When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. Immunity 2008;29:12-20.
47. Leulier F, Lemaitre B. Toll-like receptors - taking an evolutionary approach. Nat Rev Genet 2008;9:165-178 (Pubitemid 351271799)
48. Kim YM, Brinkmann MM, Paquet ME, Ploegh HL. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 2008;452:234-238
49. Brinkmann MM, Spooner E, Hoebe K, Beutler B, Ploegh HL, Kim YM. The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J Cell Biol 2007;177:265-275
50. Poltorak A, Smimova I, He X, Liu MY, Van Huffel C, McNally O et al. Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol Dis 1998;24:340-355
51. Kalis C, Kanzler B, Lembo A, Poltorak A, Galanos C, Freudenberg MA. Toll-like receptor 4 expression levels determine the degree of LPS-susceptibility in mice. Eur J Immunol 2003;33:798-805. (Pubitemid 36367683)
52. Freudenberg MA, Tchaptchet S, Keck S, Fejer G, Huber M, Schutze N et al. Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: benefits and hazards of LPS hypersensitivity. Immunobiology 2008;213:193-203.
53. Rassa JC, Meyers JL, Zhang Y, Kudaravalli R, Ross SR. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci USA 2002;99:2281-2286 (Pubitemid 34169052)
54. Burzyn D, Rassa JC, Kim D, Nepomnaschy I, Ross SR, Piazzon I. Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus. J Virol 2004;78:576-584 (Pubitemid 38067579)
55. Jiang Z, Georgel P, Du A, Shamel L, Sovath S, Mudd S et al. CD14 is required for MyD88-independent LPS signaling. Nat Immunol 2005;6:565-570 (Pubitemid 41710726)
56. Viemann D, Schmidt M, Tenbrock K, Schmid S, Muller V, Klimmek K et al. The contact allergen nickel triggers a unique inflammatory and proangiogenic gene expression pattern via activation of NF-kappaB and hypoxia-inducible factor-lalpha. J Immunol 2007;178:3198-3207 (Pubitemid 46333202)
57. Gunzer M, Riemann H, Basoglu Y, Hillmer A, Weishaupt C, Balkow S et al. Systemic administration of a TLR7 ligand leads to transient immune incompetence due to peripheral-blood leukocyte depletion. Blood 2005;106:2424-2432 (Pubitemid 41510816)
58. Khader SA, Pearl JE, Sakamoto K, Gilmartin L, Bell GK, Jelley-Gibbs DM et al. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J Immunol 2005;175:788-795 (Pubitemid 41094960)
59. Artik S, von Vultee C, Gleichmann E, Schwarz T, Griem P. Nickel allergy in mice: enhanced sensitization capacity of nickel at higher oxidation states. J Immunol 1999;163:1143-1152 (Pubitemid 29352728)
60. Sato N, Kinbara M, Kuroishi T, Kimura K, Iwakura Y, Ohtsu H et al. Lipopolysaccharide promotes and augments metal allergies in mice, dependent on innate immunity and histidine decarboxylase. Clin Exp Allergy 2007;37:743-751 (Pubitemid 46643062)
61. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045. (Pubitemid 24140436)
62. Janeway Jr. CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216. (Pubitemid 34293424)
63. Seong SY, Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 2004;4:469-478 (Pubitemid 38745558)
64. Jiang D, Liang J, Li Y, Noble PW. The role of Toll-like receptors in non-infectious lung injury. Cell Res 2006;16:693-701. (Pubitemid 44258922)
65. Yusuf N, Nasti TH, Huang CM, Huber BS, Jaleel T, Lin HY et al. Heat shock proteins HSP27 and HSP70 are present in the skin and are important mediators of allergic contact hypersensitivity. J Immunol 2009;182:675-683
66. Termeer CC, Hennies J, Voith U, Ahrens T, Weiss JM, Prehm P et al. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 2000;165:1863-1870 (Pubitemid 30643136)
67. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004;279:7370-7377
68. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005;201:1135-1143 (Pubitemid 40524681)
69. Urbonaviciute V, Furnrohr BG, Meister S, Munoz L, Heyder P, De Marchis F et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 2008;205:3007-3018
70. Guillot L, Balloy V, McCormack FX, Golenbock DT, Chignard M, Si-Tahar M. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J Immunol 2002;168:5989-5992 (Pubitemid 34620010)
71. Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 2005;202:1131-1139 (Pubitemid 41464506)
72. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007;449:564-569 (Pubitemid 47525141)
73. Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005;11:1173-1179 (Pubitemid 43093664)
74. Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD, Horton MR. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 2006;177:1272-1281 (Pubitemid 44036633)
75. Lokeshwar VB, Gomez P, Kramer M, Knapp J, McCornack MA, Lopez LE et al. Epigenetic regulation of HYAL-1 hyaluronidase expression, identification of HYAL-1 promoter. J Biol Chem 2008;283:29215-29227
76. Soltes L, Mendichi R, Kogan G, Schiller J, Stankovska M, Arnhold J. Degradative action of reactive oxygen species on hyaluronan. Biomacromolecules 2006;7:659-668 (Pubitemid 46534332)
77. Gao F, Koenitzer JR, Tobolewski JM, Jiang D, Liang J, Noble PW et al. Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan. J Biol Chem 2008;283:6058-6066
78. Eberlein M, Scheibner KA, Black KE, Collins SL, Chan-Li Y, Powell JD et al. Anti-oxidant inhibition of hyaluronan fragment-induced inflammatory gene expression. J Inflamm 2008;5:20.
79. Na K, Kim KE, Park ST, Kim TY. EC-SOD suppresses contact hypersensitivity in mouse skin by impairing Langerhans cell migration. J Invest Dermatol 2007;127:1930-1937 (Pubitemid 47075360)
80. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 2004;279:17079-17084 (Pubitemid 38560463)
81. Mummert ME, Mohamadzadeh M, Mummert DI, Mizumoto N, Takashima A. Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking. J Exp Med 2000;192:769-779 (Pubitemid 30737584)
82. Di Nardo A, Braff MH, Taylor KR, Na C, Granstein RD, McInturff JE et al. Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization. J Immunol 2007:178:1829-34. (Pubitemid 46154655)
83. Morioka Y, Yamasaki K, Leung D, Gallo RL. Cathelicidin antimicrobial peptides inhibit hyaluronan-induced cytokine release and modulate chronic allergic dermatitis. J Immunol 2008;181:3915-3922
84. Shornick LP, De Togni P, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW et al. Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone. J Exp Med 1996;183:1427-1436
85. Antonopoulos C, Cumberbatch M, Dearman RJ, Daniel RJ, Kimber I, Groves RW. Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J Immunol 2001;166:3672-3677 (Pubitemid 32224888)
86. Antonopoulos C, Cumberbatch M, Mee JB, Dearman RJ, Wei XQ, Liew FY et al. IL-18 is a key proximal mediator of contact hypersensitivity and allergen-induced Langerhans cell migration in murine epidermis. J Leukoc Biol 2008;83:361-367 (Pubitemid 351225617)
87. Kool M, Petrilli V, De Smedt T, Rolaz A, Hammad H, van Nimwegen M, et al. Cutting Edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol 2008;181:3755-3759
88. Eisenbarth SC, Colegio OR, O'Connor W, Sutterwala FS, Flavell RA. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008;453:1122-6. (Pubitemid 351871731)
89. Halle A, Homung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 2008;9:857-865
90. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 2008;9:847-856
91. Sharp FA, Ruane D, Claass B, Creagh E, Harris J, Malyala P et al. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc Natl Acad Sci USA 2009;106:870-5.
92. Ng G, Sharma L, Ward SM, Desrosiers MD, Stephens LA, Schoel WM et al. Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells. Immunity 2008;29:807-818
93. Liu L, Inoue H, Nakayama H, Kanno R, Kanno M. The endogenous danger signal uric Acid augments contact hypersensitivity responses in mice. Pathobiology 2007;74:177-185 (Pubitemid 47094062)
94. Di Virgilio F. Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol Sci 2007;28:465-472 (Pubitemid 47368700)
95. Granstein RD, Ding W, Huang J, Holzer A, Gallo RL, Di Nardo A et al. Augmentation of cutaneous immune responses by ATP gamma S: purinergic agonists define a novel class of immunologic adjuvants. J Immunol 2005;174:7725-7731
96. Mizumoto N, Kumamoto T, Robson SC, Sevigny J, Matsue H, Enjyoji K et al. CD39 is the dominant Langerhans cell-associated ecto-NTP-Dase: modulatory roles in inflammation and immune responsiveness. Nat Med 2002;8:358-365 (Pubitemid 34407030)
97. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007;204:1257-1265 (Pubitemid 46919862)
98. Toebak MJ, Moed H, von Blomberg MB, Bruynzeel DP, Gibbs S, Scheper RJ et al. Intrinsic characteristics of contact and respiratory allergens influence production of polarizing cytokines by dendritic cells. Contact Dermatitis 2006;55:238-245 (Pubitemid 44350949)
99. Dearman RJ, Humphreys N, Skinner RA, Kimber I. Allergen-induced cytokine phenotypes in mice: role of CD4 and CD8 T cell populations. Clin Exp Allergy 2005;35:498-505. (Pubitemid 40577244)
100. Takeshita K, Yamasaki T, Akira S, Gantner F, Bacon KB. Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse. Int Immunol 2004;16:685-695
101. Martin S, Lappin MB, Kohler J, Delattre V, Leicht C, Preckel T et al. Peptide Immunization Indicates that CD8+ T Cells are the Dominant Effector Cells in Trinitrophenyl-Specific Contact Hypersensitivity. J Invest Dermatol 2000;115:260-266 (Pubitemid 30637196)
102. Martin SF, Dudda JC, Delattre V, Bachtanian E, Leicht C, Burger B et al. Fas-mediated inhibition of CD4+ T cell priming results in dominance of type 1 CD8+ T cells in the immune response to the contact sensitizer trinitrophenyl. J Immunol 2004;173:3178-3185 (Pubitemid 39142024)
103. Hosogi M, Tonogaito H, Aioi A, Hamada K, Shimoda K, Muromoto R et al. Hapten-induced contact hypersensitivity is enhanced in Tyk2-deficient mice. J Dermatol Sci 2004;36:51-56 (Pubitemid 39370025)
104. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008;133:775-787 (Pubitemid 351707693)
105. Ikezawa Y, Nakazawa M, Tamura C, Takahashi K, Minami M, Ikezawa Z. Cyclophosphamide decreases the number, percentage and the function of CD25+ CD4+ regulatory T cells, which suppress induction of contact hypersensitivity. J Dermatol Sci 2005;39:105-112 (Pubitemid 41073976)
106. Seidel-Guyenot W, Perschon S, Dechant N, Alt R, Knop J, Steinbrink K. Low zone tolerance induced by systemic application of allergens inhibits Tc1-mediated skin inflammation. J Allergy Clin Immunol 2006;117:1170-1177
107. Dubois B, Chapat L, Goubier A, Papiernik M, Nicolas JF, Kaiserlian D. Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation. Blood 2003;102:3295-3301 (Pubitemid 37314769)
108. Goubier A, Dubois B, Gheit H, Joubert G, Villard-Truc F, Asselin-Paturel C et al. Plasmacytoid dendritic cells mediate oral tolerance. Immunity 2008;29:464-475
109. Dudda JC, Perdue N, Bachtanian E, Campbell DJ. Foxp3+ regulatory T cells maintain immune homeostasis in the skin. J Exp Med 2008;205:1559-1565 (Pubitemid 351962019)
110. Ring S, Schafer SC, Mahnke K, Lehr HA, Enk AH. CD4+ CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue. Eur J Immunol 2006;36:2981-2992 (Pubitemid 44782572)
111. Mahnke K, Ring S, Johnson TS, Schallenberg S, Schonfeld K, Storn V et al. Induction of immunosuppressive functions of dendritic cells in vivo by CD4+CD25+ regulatory T cells: role of B7-H3 expression and antigen presentation. Eur J Immunol 2007;37:2117-2126
112. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008;28:639-650 (Pubitemid 351636247)
113. Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 2007;8:1095-1104 (Pubitemid 47423757)
114. Dudda JC, Martin SF. Tissue-targeting of T cells by Dendritic cells and microenvironments. Trends Immunol 2004;25:417-421
115. Sigmundsdottir H, Butcher EC. Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat Immunol 2008;9:981-987
116. Dudda JC, Simon JC, Martin S. Dendritic cell immunization route determines CD8+ T cell trafficking to inflamed skin. Role for tissue microenvironment and Dendritic cells in establishment of T cell homing subsets. J Immunol 2004;172:857-863 (Pubitemid 38113742)
117. Dudda JC, Lembo A, Bachtanian E, Huehn J, Siewert C, Hamann A et al. Dendritic cells govern induction and reprogramming of polarized tissue-selective homing receptor patterns of T cells: Important role for soluble factors and tissue microenvironment. Eur J Immunol 2005;35:1056-1065 (Pubitemid 40542212)
118. Edele F, Molenaar R, Gütle D, Dudda JC, Jakob T, Homey B et al. Instructive role of peripheral tissue cells in the imprinting of T cell homing receptor patterns. J Immunol 2008;181:3745-3749.
119. Lampen A, Meyer S, Amhold T, Nau H. Metabolism of vitamin A and its active metabolite all-trans-retinoic acid in small intestinal enterocytes. J Pharmacol Exp Ther 2000;295:979-985 (Pubitemid 30951555)
120. Saurer L, McCullough KC, Summerfield A. In vitro induction of mucosa-type dendritic cells by all-trans retinoic Acid. J Immunol 2007;179:3504-3514
121. Hammerschmidt SI, Ahrendt M, Bode U, Wahl B, Kremmer E, Forster R et al. Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo. J Exp Med 2008;205:2483-90.
122. Sens-it-iv. Hopepage [Internet]. Available from www.sens-it-iv.eu [cited 2009, Mar 11].